TELK -- Telik, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TELK -- Telik, Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (4)	10/13/2000 10:05:43 PM
From: JFitnich	Read Replies (1) of 887

Some info for the thread: Lockup period expires Feb 7, 2001. 14.983 million shares available (68.8% of common). 2nd lockup period expires March 31, 2001. 1.167 million shares available (5.4%) (All info from unlockdates.com) Lehman (lead underwriter) report says complete Phase 1 data for TLK286 (resistant cancers) will be presented at the European Organization for Research & Treatment of Cancer (EORTC) in Amsterdam November 7-10. Analyst is Leheny. Also interesting from the report (and this probably belongs on the valuation thread) is that they discount TELK 2004 earnings back at 35% which I think may be a little optimistic. I'd like to see the Phase 1 results and then get down to 35% if they show promise. My opinion only. I guess it's a moot point anyway, I never pay attention to price targets. Just thought it was interesting. Maybe Lehman's attempting to be a bit more positive to "support" the stock. (Hopefully not like SGMO) OT - Rick - Answer to an earlier query, I do hope to start posting a little more. I have been moving & traveling (job related) but have been keeping tabs on SI. Take care, JF

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next